Annual Reports :: Navidea Biopharmaceuticals, Inc. (NAVB)

Filing Type:

Year:

Date	Form	Description	Pages
03/27/23	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-21.1 EX-23.1 EX-24.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	110
03/28/22	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-21.1 EX-23.1 EX-24.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	106
03/26/21	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-21.1 EX-23.1 EX-24.1 EX-31.1 EX-32.1	109
03/18/20	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-4.3 EX-10.27 EX-10.28 EX-21.1 EX-23.1 EX-24.1 EX-31.1 EX-32.1	125
03/15/19	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-21.1 EX-23.1 EX-24.1 EX-31.1 EX-32.1	118
03/15/18	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-21.1 EX-23.1 EX-23.2 EX-24.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	142
03/31/17	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-3.1 EX-21.1 EX-23.1 EX-23.2 EX-24.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	151
03/16/17	NT 10-K	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT	3
03/23/16	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-21.1 EX-23.1 EX-24.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	122
03/16/16	NT 10-K	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT	4